H. Lundbeck A/S (HLBBF)
OTCMKTS
· Delayed Price · Currency is USD
5.35
0.00 (0.00%)
At close: Jun 20, 2025
H. Lundbeck Market Cap
H. Lundbeck has a market cap or net worth of $5.37 billion as of June 27, 2025. Its market cap has increased by 4.65% in one year.
Market Cap
5.37B
Enterprise Value
7.33B
Revenue
3.33B
Ranking
n/a
PE Ratio
11.26
Stock Price
$5.35
Market Cap Chart
Since June 10, 2022, H. Lundbeck's market cap has increased from 4.54B to 5.37B, an increase of 18.23%. That is a compound annual growth rate of 5.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 5.46B | -0.43% |
| Dec 30, 2024 | 5.49B | 16.62% |
| Dec 29, 2023 | 4.70B | 28.73% |
| Dec 30, 2022 | 3.65B | -19.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Elite Pharmaceuticals | 816.24M |
| Veradigm | 764.23M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 454.40M |
| American Oncology Network | 420.90M |
| CytoDyn | 382.56M |